Drug intelligence / Profile preview

Néo-Décongestine

Development stage
Unknown
Lead developer
Melisana
Modality
Small Molecules
Administration
Topical
01

Overview

Néo-Décongestine (also marketed as Néo-Décongestine hot & cold) is a topical paste formulation containing salicylic acid as its active ingredient, along with kaolin, methyl salicylate, glycerol, eucalyptus oil, and peppermint oil. Developed by Melisana Healthcare (part of the Klosterfrau Healthcare Group) and previously by Sanopharm, it is used as a hot or cold compress (cataplasm) for the external treatment of muscle and joint rheumatism, bruises, sprains, bursitis, tendinitis, and sore throats associated with colds. Salicylic acid acts as a weak inhibitor of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), reducing the synthesis of pro-inflammatory prostaglandins to alleviate pain and inflammation locally.

Brand names
Néo-DécongestineNéo-Décongestine hot & cold
Other names
Neo-DecongestineNeo-Decongestine hot & coldNéo-Décongestine hot&cold
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IKBKB (IKKβ)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Néo-Décongestine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Néo-Décongestine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call